Received Aug 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
Generic flu like symptoms; lymph node enlargement; This is a spontaneous report received from an Other HCP. A female patient received BNT162b2 (BNT162B2), in 2022 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 2021, for COVID-19 Immunization, reaction(s): "Generic flu like symptoms", "lymph node enlargement". The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Generic flu like symptoms"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph node enlargement". Additional Information: Clarified today, 18Aug2025, is day caller made aware of adverse events. Clarified, there were 2 different side effects. Lymph node enlargement: When caller asked when this side effect started, caller states, there were 2 side effects, reporter was saying to caller, that would usually occur every time she got Covid vaccine, back in 2021, 2022, 2023. That is what reporter is guessing. This occurred when getting 2 dose primary series, occurring both with first and second doses. The lymph node enlargement required her to get a mammogram, and lasted about 6 months. Generic flu like symptoms: Clarified second side effect as, just generic flu like symptoms, lasted about 4 days. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.